Growth Metrics

Oscar Health (OSCR) Receivables - Net (2020 - 2025)

Oscar Health's Receivables - Net history spans 6 years, with the latest figure at $442.6 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 40.13% year-over-year to $442.6 million; the TTM value through Dec 2025 reached $442.6 million, up 40.13%, while the annual FY2025 figure was $442.6 million, 40.13% up from the prior year.
  • Receivables - Net reached $442.6 million in Q4 2025 per OSCR's latest filing, down from $445.5 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $488.8 million in Q1 2025 to a low of $75.9 million in Q1 2021.
  • Average Receivables - Net over 5 years is $258.4 million, with a median of $211.3 million recorded in 2022.
  • Peak YoY movement for Receivables - Net: skyrocketed 111.89% in 2021, then dropped 7.02% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $138.4 million in 2021, then soared by 56.4% to $216.5 million in 2022, then decreased by 7.02% to $201.3 million in 2023, then surged by 56.95% to $315.9 million in 2024, then surged by 40.13% to $442.6 million in 2025.
  • Per Business Quant, the three most recent readings for OSCR's Receivables - Net are $442.6 million (Q4 2025), $445.5 million (Q3 2025), and $465.4 million (Q2 2025).